Johnson & Johnson (JNJ) News Today
No Johnson & Johnson (JNJ) headline in the last 7 days moved the stock by 0.35% or more. The 2 measured moves are in the table below.
Latest headline on this page:
2 headlines on Johnson & Johnson appeared in our news feed in the last 7 days with a measured price reaction attached. The largest measured reaction was -0.13% over 10 minutes on JNJ, after the headline at Oct 19, 08:02:55 ET.
Price action when the news broke
08:02:55 ET
What moved JNJ — last 7 days
| Time | Headline | 1 min | Reaction |
|---|---|---|---|
| Oct 19, 08:02:55 ET | Johnson & Johnson (JNJ) plans to publish Tremfya findings covering 48‑week treatment in Crohn’s disease. | 0.00% | -0.13% · 10m |
| Oct 19, 08:00:01 ET | Johnson & Johnson reports data showing Tremfya (guselkumab) was the only IL-23 treatment to deliver durable fistula remission through 48 weeks in Crohn’s disease with perianal fistula | 0.00% | -0.12% · 10m |
Moves are measured against the price two minutes before each headline crossed, using validated 1-minute bars captured at publish time. A dash means no bar was available for that window. Reaction pending means the measuring window for that headline is still open. Not attributed means the headline does not name the company the move was measured on, so we hold the number back. Times are New York ET. Headlines appear here 1 minute after they cross the live tape.